Back to Search Start Over

Does a regular nurse-led distress screening and discussion improve quality of life of breast cancer patients treated with curative intent? A randomized controlled trial.

Authors :
Ploos van Amstel, Floortje K.
Peters, Marlies E. W. J.
Donders, Rogier
Schlooz‐Vries, Margrethe S.
Polman, Lenny J. M.
Graaf, Winette T. A.
Prins, Judith B.
Ottevanger, Petronella B.
Schlooz-Vries, Margrethe S
van der Graaf, Winette T A
Source :
Psycho-Oncology. Apr2020, Vol. 29 Issue 4, p719-728. 10p. 1 Diagram, 3 Charts, 2 Graphs.
Publication Year :
2020

Abstract

<bold>Objective: </bold>We performed a randomized controlled trial (RCT) to investigate whether regular screening with the distress thermometer (DT) by a nurse improved global quality of life (QOL) of patients with breast cancer (BC) treated with curative intent.<bold>Methods: </bold>BC patients were randomized between regular screening for distress with a nurse-led DT intervention (NDTI) and usual care (UC). Both groups filled out questionnaires at baseline, after each received treatment modality and at follow-up visits up to 2 years. At these points, the intervention group received also the NDTI. The primary outcome was the global QOL of the EORTC QLQ C30 at 2 years after the end of treatment. Analyses were done on an intention-to-treat basis, using analysis of covariance (ANCOVA), generalized least squares, and interaction analyses.<bold>Results: </bold>Of 194 randomized patients, 153 filled out the questionnaires up to 2 years after treatment. There was no significant difference between NDTI and UC in global QOL 2 years after the end of treatment (mean diff. = -1∙273, P = .610; 95% CI [-6.195; 3.649]). Subgroup analysis of patients who received multimodality treatment (surgery, radiotherapy, and chemotherapy, n = 66) showed a significant between-group difference in global QOL over time (mean diff. = -10, P < .001; 95% CI [-14.835; -5.167]) together with other secondary outcome measures in favor of the NDTI.<bold>Conclusion: </bold>NDTI did not lead to a significant improvement in global QOL 2 years after the end of treatment for patients with BC. However, the findings indicate that BC patients who received multimodality treatment may benefit from NDTI. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10579249
Volume :
29
Issue :
4
Database :
Academic Search Index
Journal :
Psycho-Oncology
Publication Type :
Academic Journal
Accession number :
142949431
Full Text :
https://doi.org/10.1002/pon.5324